GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vir Biotechnology VIR · USD

Health Care · US listing · 🇺🇸 United States

Compare

13.65

+11.75%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Largest shareholders

As filed, so dates differ, and a group and its funds can both appear.

HolderSharesStakeChangeFiled
BLACKROCK, INC.18m11.27%+1.7m31 Mar 2026
BlackRock Institutional Trust Company, N.A.14.1m8.81%+357.1k31 Dec 2025
SB Investment Advisers (UK) Limited13.1m8.21%−1.3m31 Dec 2025
ARCH Venture Partners12.9m8.08%—27 Feb 2026
ARCH VENTURE MANAGEMENT, LLC12.9m8.08%—31 Mar 2026
The Vanguard Group, Inc.12.5m7.84%−250.4k31 Dec 2025
SB INVESTMENT ADVISERS (UK) LTD10.9m6.85%−2.2m31 Mar 2026
VANGUARD PORTFOLIO MANAGEMENT LLC9.2m5.77%+9.2m31 Mar 2026
GSK plc8.6m5.35%—31 Dec 2025
GSK PLC8.6m5.35%—31 Mar 2026
STATE STREET CORP7.1m4.47%+911.5k31 Mar 2026
State Street Investment Management (US)6.2m3.90%+988.3k31 Dec 2025
VANGUARD CAPITAL MANAGEMENT LLC5.4m3.37%+5.4m31 Mar 2026
GOLDMAN SACHS GROUP INC3.3m2.03%+1.7m31 Mar 2026
MORGAN STANLEY2.9m1.79%+175.1k31 Mar 2026

Insider trades

Purchases and sales by directors and officers, as filed with the regulator

DateWhoTypeSharesPriceValue
1 Apr 2026 ↗SATO VICKI LDirectorSale22k9.07$199,617
23 Mar 2026 ↗Sabatini BrentSVP, Chief Accounting OfficerSale7.7k9.12$70,324
2 Mar 2026 ↗SATO VICKI LDirectorSale22k9.51$209,181
25 Feb 2026 ↗Eisner MarkEVP and Chief Medical OfficerSale1.9k9.82$18,550
25 Feb 2026 ↗de Verneuil VaninaEVP, General Counsel, Corp SecSale13.7k9.82$134,534
24 Feb 2026 ↗O'Byrne JasonEVP & Chief Financial OfficerSale1.6k9.53$15,576
24 Feb 2026 ↗SATO VICKI LDirectorSale42.4k9.75$413,366
24 Feb 2026 ↗Sabatini BrentSVP, Chief Accounting OfficerSale1.4k9.53$13,632
24 Feb 2026 ↗Eisner MarkEVP and Chief Medical OfficerSale1.6k9.53$15,405
24 Feb 2026 ↗de Verneuil VaninaEVP, General Counsel, Corp SecSale3.1k9.53$29,713
24 Feb 2026 ↗De Backer MarianneChief Executive OfficerSale14.8k9.53$140,720
23 Feb 2026 ↗Sabatini BrentSVP, Chief Accounting OfficerSale1.8k7.45$13,631
23 Feb 2026 ↗Eisner MarkEVP and Chief Medical OfficerSale2.1k7.45$15,569
23 Feb 2026 ↗O'Byrne JasonEVP & Chief Financial OfficerSale2.1k7.45$15,569
23 Feb 2026 ↗de Verneuil VaninaEVP, General Counsel, Corp SecSale4.4k7.45$33,128

Short interest

Shares sold short, 15 Oct 2026. US exchange data.

16.2m

+8.4% on the period before. 6.9 days to cover.

Short volume

Share of the day's trading sold short, 4 Nov 2026

73.4%

Last 60 trading days.

Failed deliveries

Shares not delivered on settlement, from the SEC

  • 31 Aug 202636 shares
  • 19 Aug 20265,093 shares
  • 17 Aug 202672 shares
  • 11 Aug 20261,445 shares

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.